MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

ProNAi Therapeutics Company Profile (NASDAQ:DNAI)

Consensus Ratings for ProNAi Therapeutics (NASDAQ:DNAI) (?)
Ratings Breakdown: 4 Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $33.67 (450.11% upside)

Analysts' Ratings History for ProNAi Therapeutics (NASDAQ:DNAI)
Show:
DateFirmActionRatingPrice TargetActions
3/4/2016WedbushReiterated RatingOutperform$36.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/20/2015Jefferies GroupReiterated RatingBuy$30.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/8/2015SunTrustInitiated CoverageBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/10/2015Bank of AmericaInitiated CoverageBuy$35.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 5/25/2014 forward)
            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha